Hyperprolactinemia
|
0.760 |
Biomarker
|
disease |
BEFREE |
Similarly, genetic studies have begun to reveal how differences in prolactin receptor function may account for some of the previously 'idiopathic' cases of hyperprolactinemia and bring to light new causes of prolactinomas.
|
31045655 |
2019 |
Hyperprolactinemia
|
0.760 |
Biomarker
|
disease |
BEFREE |
Variant Prolactin Receptor in Agalactia and Hyperprolactinemia.
|
30575453 |
2018 |
Hyperprolactinemia
|
0.760 |
AlteredExpression
|
disease |
BEFREE |
Downregulation of Prlr gene expression in the duodenum may explain the diminished intestinal calcium absorption in medicamentous hyperprolactinaemia.
|
30143940 |
2018 |
Hyperprolactinemia
|
0.760 |
AlteredExpression
|
disease |
BEFREE |
Both purinergic and prolactin receptor expression changes occur during the anti-asthmatic effect of hyperprolactinemia.
|
29874677 |
2018 |
Hyperprolactinemia
|
0.760 |
Biomarker
|
disease |
BEFREE |
Antipsychotics are the most common pharmacological agents which cause hyperprolactinemia The aim of this review is to describe PRL physiology, PRL biological effects and pathway to the diagnosis, causes, consequences of HPRL focusing on the antipsychotic effects on the PRL.
|
28440197 |
2017 |
Hyperprolactinemia
|
0.760 |
GeneticVariation
|
disease |
BEFREE |
We focus on the role of prolactin in human pathophysiology, particularly the discovery of the mechanism underlying infertility associated with hyperprolactinaemia and the identification of the first mutation in human PRLR.
|
25781857 |
2015 |
Hyperprolactinemia
|
0.760 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutant prolactin receptor and familial hyperprolactinemia.
|
24195502 |
2013 |
Hyperprolactinemia
|
0.760 |
GeneticVariation
|
disease |
UNIPROT |
Mutant prolactin receptor and familial hyperprolactinemia.
|
24195502 |
2013 |
Hyperprolactinemia
|
0.760 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hyperprolactinemia
|
0.760 |
Biomarker
|
disease |
CTD_human |
|
|
|
MULTIPLE FIBROADENOMAS OF THE BREAST
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
|
18779591 |
2008 |
MULTIPLE FIBROADENOMAS OF THE BREAST
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
MULTIPLE FIBROADENOMAS OF THE BREAST
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Miscarriage
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Genotype distribution at an SNP (rs37389) in the prolactin receptor gene (P = 0.03), and allele distributions at an SNP (rs41423247) in the glucocorticoid receptor gene (P = 0.04) and an STR polymorphism in the estrogen receptor β gene (P = 0.03) were associated with recurrent miscarriage.
|
20716560 |
2010 |
Miscarriage
|
0.310 |
Biomarker
|
disease |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Endometriosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Endometrioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Spontaneous abortion
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Abortion, Tubal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes controlling affiliative behavior as candidate genes for autism.
|
18207134 |
2008 |
Early Pregnancy Loss
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
Carcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
Furthermore, carcinomas with elevated pY-STAT5a demonstrated lower apoptosis as measured by the TUNEL assay and the Bcl-2 to Bax ratio, and showed increased expression of the long and short isoforms of the prolactin receptor.
|
17173897 |
2007 |
Animal Mammary Neoplasms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Proliferation and apoptosis in PhIP-induced rat mammary gland carcinomas with elevated phosphotyrosine-STAT5a.
|
17173897 |
2007 |
Anaplastic carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proliferation and apoptosis in PhIP-induced rat mammary gland carcinomas with elevated phosphotyrosine-STAT5a.
|
17173897 |
2007 |